United States News Todas as matérias

Kremlin insiders have reportedly drafted a bold proposal to re-embrace the US dollar as part of a sweeping economic reset pitched to a potential Donald Trump administration.

Figure Technology Solutions (NASDAQ:FIGR) signaled a massive acceleration in the adoption of blockchain-based lending, reporting that its consumer loan marketplace volume more than doubled in the final quarter of 2025.

AtlasClear Holdings (NYSE:ATCH), a technology-driven financial services company focused on capital markets infrastructure, clearing, and brokerage solutions, today reported financial results for its second fiscal quarter ended December 31, 2025.

PodcastOne (NASDAQ:PODC) raised its full-year financial outlook on Friday, signaling that its strategy of converting popular audio titles into television properties is beginning to yield significant high-margin returns.

CBL Properties (NYSE:CBL), a real estate investment trust focused on open-air lifestyle centers, malls, and outlet centers, reported financial and operational results for the fourth quarter and full year ended December 31, 2025.

Encino, California-based Marcus & Millichap (NYSE:MMI), a leading national real estate services firm specializing in commercial real estate investment sales, financing, research, and advisory services, reported preliminary financial results for the fourth quarter and full year 2025.

Dauch (NYSE:DCH), the newly rebranded automotive supplier formerly known as American Axle & Manufacturing, signaled a massive scale-up for 2026 after closing its transformational acquisition of Dowlais Group.

Citius Oncology (NASDAQ:CTOR) officially transitioned from a development-stage clinical trial outfit to a revenue-generating commercial entity this quarter, posting its first sales of the newly approved immunotherapy LYMPHIR.

Helus Pharma (NASDAQ:HELP) reported financial results and clinical progress for the third quarter of fiscal 2026 ended December 31, 2025, highlighting a solid cash position and advancing late-stage programs targeting major psychiatric indications.

Astrotech (NASDAQ:ASTC) signaled a major pivot from development to commercialization in its fiscal second-quarter results, slashing research spending as its flagship mass spectrometry devices gain a foothold in international security and environmental markets.

Beyond Air (NASDAQ:XAIR) reported a surge in third-quarter revenue and a strategic pivot toward its core respiratory business, announcing a binding agreement to divest its autism and neuro-oncology subsidiary to XTL Biopharmaceuticals.

Colliers International Group (NASDAQ:CIGI) reported double-digit growth in its 2025 fiscal year and moved to significantly expand its footprint in the high-margin engineering sector, announcing a $700 million (USD) deal to acquire Spain-based Ayesa Engineering.

Sensient Technologies (NYSE:SXT) reported a 4.5% increase in fourth-quarter revenue, fueled by a surge in new business wins that helped offset the heavy lifting of a multi-year corporate restructuring.

Enbridge (NYSE:ENB) reported record financial results for 2025, meeting its guidance for the 20th consecutive year and providing a stable outlook for 2026 as it leverages a massive backlog of energy infrastructure projects.

Rithm Property Trust (NYSE:RPT) reported a profitable fourth quarter on a GAAP basis, though the real estate investment trust continues to navigate a gap between its core distributable earnings and its shareholder payout levels.

Atmus Filtration Technologies (NYSE:ATMU) reported fourth-quarter earnings that surpassed analyst estimates, capping a transformational year for the Cummins spin-off as it pivots toward high-growth industrial and data center markets.

PowerBank (NASDAQ:SUUN) reported a significant narrowing of its net loss for the first half of fiscal 2026, as the renewable energy developer pivots toward a more capital-efficient model and locks in a massive construction pipeline in the Northeastern U.S.

Moderna (NASDAQ:MRNA) reported a massive full-year loss and revealed a significant regulatory setback in the U.S., as the Food and Drug Administration refused to review its experimental flu vaccine, complicating the biotech’s path to profitability.

The Wendy’s Company (NASDAQ:WEN) reported a sharp decline in fourth-quarter global sales, as persistent headwinds in the U.S. fast-food market overshadowed continued momentum in its international business.

Essent Group (NYSE:ESNT) reported strong full-year profitability and underscored its commitment to capital management by returning nearly $700 million to shareholders in 2025, driven by a massive stock repurchase program.

Cameco (NYSE:CCJ) reported a surge in fourth-quarter and full-year profit, capitalizing on a robust uranium market and a lucrative payout from its strategic stake in Westinghouse Electric that allowed the Canadian miner to hike its dividend ahead of schedule.

Advance Auto Parts (NYSE:AAP) signaled a decisive turn in its multi-year recovery effort, reporting fourth-quarter results that swung from a massive prior-year loss to positive territory.

Gravity (NASDAQ:GRVY), the South Korean developer behind the long-standing Ragnarok franchise, reported preliminary unaudited financial results for the fourth quarter and full year of 2025, revealing a sequential dip in profitability even as it gears up for a heavy release schedule in 2026.

Applied Materials (NASDAQ:AMAT) shares surged 11.7% in premarket trading Friday, leading a broad rally across the semiconductor sector after the company issued a second-quarter forecast that shattered Wall Street estimates.